| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 54.690 | 81.540 | 95.351 | 117.017 | 129.510 | 85.663 | 108.872 | 130.778 | 123.405 | 125.532 |
| Total Income - EUR | 54.705 | 81.618 | 95.976 | 118.234 | 130.223 | 86.868 | 109.739 | 131.634 | 124.522 | 126.375 |
| Total Expenses - EUR | 57.915 | 81.292 | 96.032 | 115.613 | 134.643 | 91.031 | 109.448 | 134.694 | 125.577 | 129.195 |
| Gross Profit/Loss - EUR | -3.210 | 326 | -56 | 2.620 | -4.420 | -4.163 | 292 | -3.060 | -1.055 | -2.821 |
| Net Profit/Loss - EUR | -3.210 | -1.149 | -1.016 | 1.438 | -5.721 | -4.965 | -807 | -4.378 | -2.302 | -5.996 |
| Employees | 2 | 2 | 1 | 2 | 3 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Savilucprim Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 1.001 | 13.413 | 8.935 | 5.587 | 1.429 | 421 | 140 |
| Current Assets | 5.543 | 5.570 | 9.014 | 9.887 | 9.835 | 8.341 | 11.763 | 14.453 | 12.279 | 8.729 |
| Inventories | 4.612 | 4.817 | 7.549 | 7.805 | 7.266 | 4.806 | 8.346 | 10.390 | 7.076 | 6.393 |
| Receivables | 280 | 175 | 274 | 445 | 532 | 730 | 940 | 586 | 1.519 | 1.080 |
| Cash | 650 | 579 | 1.191 | 1.636 | 2.038 | 2.804 | 2.477 | 3.477 | 3.683 | 1.256 |
| Shareholders Funds | -24.266 | -25.168 | -25.758 | -23.847 | -29.106 | -33.520 | -33.584 | -38.066 | -40.252 | -46.024 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 29.809 | 30.738 | 34.772 | 34.735 | 52.355 | 50.796 | 50.934 | 53.948 | 52.952 | 54.893 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4724 - 4724" | |||||||||
| CAEN Financial Year |
4724
|
|||||||||
Comments - Savilucprim Srl